Aastha Atray Banan | Mid-Day | February 6, 2022
India recently passed new Surrogacy and ART Acts, banning commercial surrogacy and germline cell sales, respectively. In this interview, author Pinki Virani acknowledges that the acts will promote a more regulated, less money-oriented fertility industry by eliminating the sale-purchase aspect of sperm and eggs and putting power in the hands of surrogates. On the other hand, Virani believes that there are still risks with IVF and third-party reproduction due to the complexity of sourcing sex cells, fertilization, implantation, and birth. In particular, she urges patients to undergo thorough screening processes to reduce the risk of genetic siblings unknowingly becoming a couple.